Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Jaffe

Showing results (161-170 of 206) with videos related to

Pageof 21
Sort By:
The European Respiratory Journal|October 9, 2025
Characteristics, treatment and lung function outcomes of pulmonary exacerbations in cystic fibrosis: insights from the BEAT-CF cohortParveen Fathima, Edward Pan, Julie Marsh, et al.
The Journal of Infectious Diseases|November 1, 2024
Clinical Characteristics and In-hospital Outcomes Associated With Respiratory Syncytial Virus vs Other Viral Acute Lower Respiratory Infections in Hospitalized Children Younger Than 2 YearsAcacia Ozturk, Mei Chan, Jahid Rahman Khan, et al.
American Journal of Respiratory and Critical Care Medicine|January 11, 2005
Potential difference measurements in the lower airway of children with and without cystic fibrosisJane C Davies, Michael Davies, Donna McShane, et al.
Trials|June 16, 2026
ORIGIN-1 trial: study protocol for an organoid-guided N-of-1 trial evaluating CFTR modulator response in cystic fibrosis with rare non-F508del mutationsLorena Rodrigues Sabino, Gerard E Kaiko, Douglas Dorahy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 30, 2017
Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10years oldMillie Garg, Steven T Leach, Tamara Pang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
A receptor-targeted nanocomplex vector system optimized for respiratory gene transferAristides D Tagalakis, Robin J McAnulty, James Devaney, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 19, 2017
Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy childrenMillie Garg, Steven T Leach, Michael J Coffey, et al.
Chemical Science|October 24, 2022
Metal-organic frameworks as O<sub>2</sub>-selective adsorbents for air separationsDavid E Jaramillo, Adam Jaffe, Benjamin E R Snyder, et al.
Microorganisms|March 27, 2025
The Prevalence of Polyketide Synthase-Positive <i>E. coli</i> in Cystic FibrosisChristopher Chan, Michael Coffey, Caitlin Murphy, et al.
BMJ Open|April 10, 2015
CareTrack Kids-part 3. Adverse events in children's healthcare in Australia: study protocol for a retrospective medical record reviewPeter D Hibbert, Andrew R Hallahan, Stephen E Muething, et al.
Pageof 21

Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
The European Respiratory Journal|October 9, 2025
Characteristics, treatment and lung function outcomes of pulmonary exacerbations in cystic fibrosis: insights from the BEAT-CF cohortParveen Fathima, Edward Pan, Julie Marsh, et al.
The Journal of Infectious Diseases|November 1, 2024
Clinical Characteristics and In-hospital Outcomes Associated With Respiratory Syncytial Virus vs Other Viral Acute Lower Respiratory Infections in Hospitalized Children Younger Than 2 YearsAcacia Ozturk, Mei Chan, Jahid Rahman Khan, et al.
American Journal of Respiratory and Critical Care Medicine|January 11, 2005
Potential difference measurements in the lower airway of children with and without cystic fibrosisJane C Davies, Michael Davies, Donna McShane, et al.
Trials|June 16, 2026
ORIGIN-1 trial: study protocol for an organoid-guided N-of-1 trial evaluating CFTR modulator response in cystic fibrosis with rare non-F508del mutationsLorena Rodrigues Sabino, Gerard E Kaiko, Douglas Dorahy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 30, 2017
Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10years oldMillie Garg, Steven T Leach, Tamara Pang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
A receptor-targeted nanocomplex vector system optimized for respiratory gene transferAristides D Tagalakis, Robin J McAnulty, James Devaney, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 19, 2017
Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy childrenMillie Garg, Steven T Leach, Michael J Coffey, et al.
Chemical Science|October 24, 2022
Metal-organic frameworks as O<sub>2</sub>-selective adsorbents for air separationsDavid E Jaramillo, Adam Jaffe, Benjamin E R Snyder, et al.
Microorganisms|March 27, 2025
The Prevalence of Polyketide Synthase-Positive <i>E. coli</i> in Cystic FibrosisChristopher Chan, Michael Coffey, Caitlin Murphy, et al.
BMJ Open|April 10, 2015
CareTrack Kids-part 3. Adverse events in children's healthcare in Australia: study protocol for a retrospective medical record reviewPeter D Hibbert, Andrew R Hallahan, Stephen E Muething, et al.
Pageof 21